Drug intelligence / Profile preview

7,12-dimethylbenz[a]anthracene

Development stage
Unknown
Modality
Small Molecules
Administration
Induction (laboratory Use, Administered To Animals—usually Oral, Topical, Or Injection)
01

Overview

**7,12-dimethylbenz[a]anthracene (DMBA)** is a polycyclic aromatic hydrocarbon (PAH) that is a potent laboratory carcinogen[1][2][3]. DMBA is used in biomedical research to induce tumors, such as mammary and skin cancers in animal models, due to its ability to be metabolically activated by microsomal enzymes into diol epoxide intermediates, which covalently bind to DNA and initiate carcinogenesis[2]. It is found in tobacco smoke and is notable as a mutagen, teratogen, and flammable solid[1][2]. DMBA exhibits selectivity for necrosis and hemorrhaging in adrenal gland tissues and inhibits plasma alkaline phosphatase activity, likely through formation of charge transfer complexes with biomolecules[2].

Other names
7,12-dimethylbenz(a)anthracene7,12-Dimethylbenzanthracene7,12-dimethyltetraphene9,10-Dimethyl-1,2-benzanthracene7,12-Dimethylbenzo[a]anthracene6,7-Dimethyl-1,2-benzanthracene1,4-Dimethyl-2,3-benzphenanthreneBenz(a)anthracene, 7,12-dimethyl-9,10-Dimethylbenz[a]anthraceneDimethylbenzanthraceneMFCD00003600MFCD-00003600MFCD 00003600BRN 1912135BRN1912135BRN-1912135CHEBI:254496NSC408823NSC-408823NSC 408823DTXSID1020510DTXSID-1020510DTXSID 1020510F05B6S0395F-05B6S0395F 05B6S0395DMBAnSKL149SKL-149SKL 149N-BENZYLDIMETHYLAMINE
02

Targets

DNA

Beyond the preview

Go deeper on 7,12-dimethylbenz[a]anthracene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 7,12-dimethylbenz[a]anthracene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call